Estée Lauder Nominates Two New Directors

Estée Lauder's nomination of Jean-Frédéric Dufour and Matthew E. Rubel arrives as the company continues a financial reset and operational transformation. For the six months ended December 31, 2025 (H1 FY2026), net sales were $7,710 million, up 5% year-over-year, and the company reported net earnings of $209 million versus a loss in the prior-year period. Diluted EPS turned positive to $0.57 for H1 FY2026, reflecting a partial recovery from the significant charges recorded in FY2025. Investors monitoring governance changes will note the nomination occurs against a backdrop of sizable one-time losses in FY2025: approximately $1.4 billion of goodwill and intangible-asset impairments (including a $773 million TOM FORD trademark impairment) and cumulative restructuring charges of roughly $680 million through June 30, 2025. The company has advanced its 'Beauty Reimagined' and Profit Recovery and Growth Plan initiatives, with cumulative restructuring-related charges of $1,228 million through December 31, 2025.

As of December 31, 2025, Estée Lauder reported $3.082 billion in cash and cash equivalents, total assets of $19.634 billion and total debt of approximately $7.3 billion, yielding a debt-to-capitalization of about 63%. Liquidity and leverage metrics remain relevant considerations for shareholders as the company executes cost actions and brand portfolio decisions announced under its transformation plan. Operationally, the company’s product and regional mix shows areas of strength and pressure: skin care represented 47.1% of H1 FY2026 sales ($3,629 million) and grew 5% year-over-year; fragrance was up 12% (19.9% of sales); makeup was broadly flat. Regionally, Mainland China contributed $1,461 million (19% of sales) and showed signs of recovery. These underlying business dynamics provide the operating context for any board-level oversight and strategic decisions following the new nominations.